Cancer pill costs soar as drug companies retain pricing power

Financial Times

28 April 2017 - Doctors have to act as financial planners to find treatment that patients can afford.

When Jean Allen-Yannotti was diagnosed with a type of leukaemia in November 2015, it was the latest blow in a long fight that had already seen her defeat breast and lip cancer. 

Her doctors prescribed a cocktail of drugs that could keep her alive for another 15 years, but now she lies awake at night worrying whether she can afford the medicine, which costs $14,000 a month.

Read Financial Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing